resorptive should be used,” she said. “I think it really depends on the individual situation. If it’s a woman who’s 48, not going to have any more children, you could definitely use a bisphosphonate. … If it’s somebody much younger and wants to have children, then you might want to avoid it. You might want to give estrogen in some situations.”
Thomas R. Collins is a freelance writer living in South Florida.
ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
References
- Cohen A, Dempster DW, Recker RR, et al. Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab. 2011 Oct;96(10):3095–3105.
- Eng-Wong J, Reynolds JC, Venzon D, et al. Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer. J Clin Endocrinol Metab. 2006 Oct;91(10):3941–3946.
- Cohen A, Stein EM, Recker RR, et al. Teriparatide for idiopathic osteoporosis in premenopausal women: A pilot study. J Clin Endocrinol Metab. 2013 May;98(5):1971–1981.